AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
BUSINESS BRIEFS.(TO THE POINT)
MEDIA
Cable companies raising prices
The biggest deliverer, Comcast, announced a 6% hike for its most popular cable package. Time Warner is upping its prices 1.9%-3.1%. Cablevision Systems will increase its rates by 2.3%. Cable rates rose 5.4% in '03, down from a 7.8% increase in '02, the FCC said. Rate hikes were smaller in areas with the highest competition, climbing 3.6%.
** Tribune's Nov. revenue fell 3.9% to $437 mil. Hurricane Wilma hurt publishing revenue, which was down 2.7% to $330 mil, and ad sales fell 2.4% to $263 mil. Shares fell 1% to 31.39.
MEDICAL
FDA panel OK's Noven patch
An experimental skin patch made by Noven Pharma to treat attention deficit hyperactivity disorder in children is safe, but its package ...
- United States : Hisamitsu completes $428M Noven Pharma purchase.
- News wire article from: TendersInfo August 29, 2009 700+ words
Byline: pinto03 Hisamitsu Pharmaceutical Co. completed its $428 million purchase of Florida-based Noven Pharmaceutical Inc., the companies said Friday. Hisamitsu agreed to buy Noven on July 14 for $16.50 per share, which was a 22.4 percent premium to the most recent closing price for Noven stock.
- FDA Panel Recommends Approval of Medtronic's InSync System for Treatment of...
- Press release article from: Business Wire July 10, 2001 700+ words
...Data from the study presented to the FDA panel showed that the study met all of its...the principal presenter in today's FDA panel meeting. "InSync provides substantial...InSync CRT system recommended by the FDA Panel today is designed for an entirely new...
- FDA Panel Recommends Approval of Medtronic Sofamor Danek's InFUSE Bone Graft...
- Press release article from: Business Wire January 10, 2002 700+ words
...product of its kind widely available. The FDA panel conditions for approval included three...medical advance achieve the milestone of an FDA panel recommendation," said Kenneth Burkus...the principal presenter at today's FDA panel meeting. A large-scale, multi-center...
- DATA PRESENTED TO FDA PANEL SHOW TAXUS.
- News wire article from: AsiaPulse News December 11, 2006 700+ words
...Contact details below.) Data Presented to FDA Panel Show TAXUS(TM) Drug-Eluting Stents...S. Food and Drug Administration (FDA) panel, showing that the TAXUS(TM) paclitaxel...following DES is one of the topics the FDA panel is expected to consider at the conclusion...
- FDA Panel Recommends Approval of Medtronic Heart Valve under Humanitarian...
- Press release article from: Business Wire July 22, 2009 700+ words
...S. Food and Drug Administration (FDA) panel's unanimous vote (12-0) to recommend...world and the first to be reviewed by an FDA panel. It received Conformite Europeenne...stays. "We are very pleased with the FDA panel's recommendation today and look forward...
- FDA Panel Recommends Approval of Medtronic's InSync ICD System for Treatment of...
- Press release article from: Business Wire March 5, 2002 700+ words
...James Young, principal presenter at the FDA panel meeting. "Approval of InSync ICD will...therapy." Clinical data presented to the FDA panel today demonstrated that, for New York...MIRACLE ICD results presented to the FDA panel reflected the experience of 362 patients...
- FDA panel nod only part of the battle facing companies.
- Newspaper article from: Medical Device Daily March 7, 2002 700+ words
FDA panel nod only part of the battle facing companies By HOLLAND JOHNSON Medical...protection of a defibrillator, said James Young, MD, another presenter at the FDA panel meeting and also an investigator in the MIRACLE trial. Approval of InSync...
- FDA panel strikes down industry effort to bring back silicone breast...
- Magazine article from: Legislative Network for Nurses April 18, 2005 700+ words
...President Kim Gandy. "Rather than succumbing to political pressure, this time the FDA panel ruled on the side of science and medicine." In a 5-to-4 vote, an FDA panel April 12 voted to reject Inamed Corp.'s application to bring silicone gel...
